Venture Certified
| 기술평가보증기업(기금) | 2020-09-22 ~ 2022-09-21 | 20200112428 | 2020-09-22 |
| 혁신성장유형 | 2022-09-22 ~ 2025-09-21 | 20220928030033 | 2020-09-22 |
| 혁신성장유형 | 2025-09-22 ~ 2028-09-21 | 20250909030072 | 2020-09-22 |
Revenue CAGR +10.7%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 7.6B | 5.8B | 6.2B |
| Operating Profit | 0.1B | -1.3B | -1.7B |
| Net Profit | 0.5B | -1.1B | -1.8B |
| Total Assets | 11B | 10B | 14B |
| Total Liabilities | 1.1B | 0.4B | 2.8B |
| Total Equity | 10B | 9.7B | 11B |
Debt Ratio Surge (+7pp YoY)
▲ 26.9%
▲ 106.7%
▲ 105.3%
▼ 26.4%
▲ 136.7%
| Name | Position | Role |
|---|---|---|
| 유정우 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "대구광역시 동구",
"ceo_name": "유정우",
"certificate": [
{
"cert_number": "20200112428",
"changes": "",
"disclosure_date": "2020-09-22",
"first_cert_date": "2020-09-22",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2020-09-22 ~ 2022-09-21"
},
{
"cert_number": "20220928030033",
"changes": "",
"disclosure_date": "2022-09-28",
"first_cert_date": "2020-09-22",
"no": "2",
"type": "혁신성장유형",
"valid_period": "2022-09-22 ~ 2025-09-21"
},
{
"cert_number": "20250909030072",
"changes": "",
"disclosure_date": "2025-09-09",
"first_cert_date": "2020-09-22",
"no": "3",
"type": "혁신성장유형",
"valid_period": "2025-09-22 ~ 2028-09-21"
}
],
"company_name": "㈜메디제이",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 142733000,
"cost_of_sales": 515284000,
"current_assets": 1265792000,
"current_liabilities": 281772000,
"gross_profit": 104553000,
"net_income": -177644000,
"net_income_bs": -177644000,
"non_current_assets": 94203000,
"non_current_liabilities": 0,
"non_operating_expenses": 211909000,
"non_operating_income": 202963000,
"operating_profit": -168698000,
"revenue": 619837000,
"sga_expenses": 273251000,
"total_assets": 1359995000,
"total_equity": 1078223000,
"total_liabilities": 281772000
},
"2023": {
"capital_stock": 142733000,
"cost_of_sales": 483004000,
"current_assets": 909693000,
"current_liabilities": 36263000,
"gross_profit": 93714000,
"net_income": -112934000,
"net_income_bs": -112934000,
"non_current_assets": 92091000,
"non_current_liabilities": 0,
"non_operating_expenses": 228541000,
"non_operating_income": 246158000,
"operating_profit": -130551000,
"revenue": 576718000,
"sga_expenses": 224265000,
"total_assets": 1001784000,
"total_equity": 965521000,
"total_liabilities": 36263000
},
"2024": {
"capital_stock": 142733000,
"cost_of_sales": 424204000,
"current_assets": 1040136000,
"current_liabilities": 112020000,
"gross_profit": 335035000,
"net_income": 52575000,
"net_income_bs": 52575000,
"non_current_assets": 89979000,
"non_current_liabilities": 0,
"non_operating_expenses": 30000,
"non_operating_income": 42530000,
"operating_profit": 10075000,
"revenue": 759239000,
"sga_expenses": 324960000,
"total_assets": 1130115000,
"total_equity": 1018095000,
"total_liabilities": 112020000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [],
"main_products": "연구개발업/하이코겔",
"phone": "010-3259-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |